MedPath

Clinical Markers of Panic and Generalized Anxiety Disorder

Completed
Conditions
Generalized Anxiety Disorder
Panic Disorder
Duration of Untreated Illness
Interventions
Diagnostic Test: Structured Clinical Interview for DSM-5
Registration Number
NCT06071819
Lead Sponsor
University of Milano Bicocca
Brief Summary

The goal of this observational study is to compare socio-demographic and clinical features in patients affected by Generalized Anxiety Disorder (GAD) and by Panic Disorder (PD). The main questions it aims to answer are:

* which socio-demographic/clinical markers are associated to GAD or PD diagnosis?

* which factors are associated with a longer duration of untreated illness (DUI) in GAD and in PD? Participants will signed a written informed consent and socio-demographic/clinical variables will be retrospectively collected. Researchers will compare GAD and PD groups in terms of socio-demographic and clinical features, including DUI, to better characterize the two disorders and to investigate factors associated to a longer DUI.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
290
Inclusion Criteria
  • age 18-65 years;
  • ability and willing to give informed consent;
  • fluency in Italian language;
  • diagnosis of GAD or PD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorder, 5th edition.
Exclusion Criteria
  • intellectual disability;
  • lack of clinical and socio-demographic information;
  • patients treated for less than three months in the outpatient clinics for the impossibility of a comprehensive collection of clinical variables.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Panic Disorder (PD)Structured Clinical Interview for DSM-5Patients affected by Panic Disorder
Generalized Anxiety Disorder (GAD)Structured Clinical Interview for DSM-5Patients affected by GAD
Primary Outcome Measures
NameTimeMethod
OccupationThree months

Occupation (employed/unemployed)

TreatmentThree months

Treatment, treatment discontinuation and side effects

SexThree months

Sex (male/female)

Substance misuseThree months

Substance misuse

Dichotomous socio-demographic / clinical variablesThree months

Multiple family history of psychiatric disorders (yes/no), pre- and post-onset psychiatric poly-comorbidities (yes/no), presence of personality disorder (yes/no), pre- and post-onset poly-substance misuse (yes/no), pre- and post-onset medical poly-comorbidities (yes/no), suicide attempts (yes/no), hospitalizations (yes/no), poly-therapy (yes/no), presence of poly-side effects (yes/no), presence of lifetime psychotherapy (yes/no)

Quantitative socio-demographic / clinical variablesThree months

Age (years), age at onset (years), duration of illness (years), duration of treatment (years)

Pre-/post-onset ComorbidityThree months

Psychiatric and medical comorbidity

Secondary Outcome Measures
NameTimeMethod
Duration of untreated illness (DUI) in months = time between the onset of PD and the first appropriate pharmacological treatment.Three months

Factors associated to DUI among GAD and PD groups. Information about DUI have been registered according to what the patient reported (clinical records and structured interviews)

Trial Locations

Locations (1)

University of Milano Bicocca - Fondazione IRCCS San Gerardo dei Tintori

🇮🇹

Monza, MB, Italy

© Copyright 2025. All Rights Reserved by MedPath